Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Gena Wang is an analyst at Barclays. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 07/24/2024
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 06/25/2024 | ALNY | Buy Now | Alnylam Pharmaceuticals | $240.90 | 20.8% | $236 → $291 | Maintains | Overweight | Get Alert |
| 06/21/2024 | SRPT | Buy Now | Sarepta Therapeutics | $148.19 | 52.51% | $185 → $226 | Maintains | Overweight | Get Alert |
| 05/16/2024 | SLDB | Buy Now | Solid Biosciences | $8.80 | 104.55% | $21 → $18 | Maintains | Overweight | Get Alert |
| 05/09/2024 | EDIT | Buy Now | Editas Medicine | $5.32 | 69.17% | $11 → $9 | Maintains | Equal-Weight | Get Alert |
| 05/09/2024 | CRSP | Buy Now | CRISPR Therapeutics | $57.49 | 16.54% | $80 → $67 | Maintains | Equal-Weight | Get Alert |
| 05/08/2024 | BEAM | Buy Now | Beam Therapeutics | $33.09 | -0.27% | $42 → $33 | Maintains | Equal-Weight | Get Alert |
| 04/15/2024 | FDMT | Buy Now | 4D Molecular Therapeutics | $19.47 | 131.12% | → $45 | Initiates | → Overweight | Get Alert |
| 04/01/2024 | KOD | Buy Now | Kodiak Sciences | $3.23 | -7.12% | $2 → $3 | Maintains | Underweight | Get Alert |
| 03/18/2024 | SLDB | Buy Now | Solid Biosciences | $8.80 | 138.64% | $8 → $21 | Maintains | Overweight | Get Alert |
| 03/07/2024 | RGNX | Buy Now | Regenxbio | $14.28 | 285.15% | $45 → $55 | Maintains | Overweight | Get Alert |
| 02/29/2024 | EDIT | Buy Now | Editas Medicine | $5.32 | 106.77% | $10 → $11 | Maintains | Equal-Weight | Get Alert |
| 02/29/2024 | SRPT | Buy Now | Sarepta Therapeutics | $148.19 | 24.84% | $141 → $185 | Maintains | Overweight | Get Alert |
| 02/28/2024 | BEAM | Buy Now | Beam Therapeutics | $33.09 | 26.93% | $26 → $42 | Maintains | Equal-Weight | Get Alert |
| 02/22/2024 | CRSP | Buy Now | CRISPR Therapeutics | $57.49 | 39.15% | $61 → $80 | Maintains | Equal-Weight | Get Alert |
| 02/06/2024 | VRTX | Buy Now | Vertex Pharmaceuticals | $495.26 | -4.7% | $446 → $472 | Maintains | Overweight | Get Alert |
| 01/24/2024 | LEGN | Buy Now | Legend Biotech | $59.99 | 56.69% | $93 → $94 | Maintains | Overweight | Get Alert |
| 12/11/2023 | VRTX | Buy Now | Vertex Pharmaceuticals | $495.26 | -16.21% | $408 → $415 | Maintains | Overweight | Get Alert |
| 12/11/2023 | CRSP | Buy Now | CRISPR Therapeutics | $57.49 | 6.11% | $56 → $61 | Maintains | Equal-Weight | Get Alert |
| 11/02/2023 | SRPT | Buy Now | Sarepta Therapeutics | $148.19 | -4.85% | $193 → $141 | Maintains | Overweight | Get Alert |
| 11/02/2023 | BMRN | Buy Now | Biomarin Pharmaceutical | $85.76 | 29.43% | $125 → $111 | Maintains | Overweight | Get Alert |
| 10/27/2023 | PTCT | Buy Now | PTC Therapeutics | $34.06 | -26.6% | $26 → $25 | Maintains | Equal-Weight | Get Alert |
| 10/18/2023 | LEGN | Buy Now | Legend Biotech | $59.99 | 55.03% | $92 → $93 | Maintains | Overweight | Get Alert |
| 09/18/2023 | PTCT | Buy Now | PTC Therapeutics | $34.06 | -23.66% | $44 → $26 | Maintains | Equal-Weight | Get Alert |
| 08/09/2023 | SGMO | Buy Now | Sangamo Therapeutics | $0.65 | 1285.68% | $11 → $9 | Maintains | Overweight | Get Alert |
| 08/09/2023 | BEAM | Buy Now | Beam Therapeutics | $33.09 | 5.77% | $41 → $35 | Maintains | Equal-Weight | Get Alert |
| 08/07/2023 | NTLA | Buy Now | Intellia Therapeutics | $26.31 | 242.08% | $86 → $90 | Maintains | Overweight | Get Alert |
| 08/04/2023 | PTCT | Buy Now | PTC Therapeutics | $34.06 | 29.18% | $48 → $44 | Maintains | Equal-Weight | Get Alert |
| 08/04/2023 | NTLA | Buy Now | Intellia Therapeutics | $26.31 | 242.08% | $148 → $90 | Maintains | Overweight | Get Alert |
| 08/02/2023 | VRTX | Buy Now | Vertex Pharmaceuticals | $495.26 | -19.44% | $384 → $399 | Maintains | Overweight | Get Alert |
| 07/25/2023 | KOD | Buy Now | Kodiak Sciences | $3.23 | -38.08% | $5 → $2 | Maintains | Underweight | Get Alert |
| 07/24/2023 | MRTX | Buy Now | Mirati Therapeutics | — | — | $75 → $71 | Maintains | Overweight | Get Alert |
| 07/21/2023 | LEGN | Buy Now | Legend Biotech | $59.99 | 53.36% | $90 → $92 | Maintains | Overweight | Get Alert |
| 07/21/2023 | VIR | Buy Now | Vir Biotechnology | $10.71 | 282.82% | $59 → $41 | Maintains | Overweight | Get Alert |
| 06/01/2023 | CRSP | Buy Now | CRISPR Therapeutics | $57.49 | 11.32% | $61 → $64 | Maintains | Equal-Weight | Get Alert |
| 06/01/2023 | BLUE | Buy Now | bluebird bio | $1.22 | 555.74% | $7 → $8 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 05/25/2023 | MRTX | Buy Now | Mirati Therapeutics | — | — | $90 → $75 | Maintains | Overweight | Get Alert |
| 05/24/2023 | PTCT | Buy Now | PTC Therapeutics | $34.06 | 40.93% | $57 → $48 | Maintains | Equal-Weight | Get Alert |
| 05/19/2023 | LEGN | Buy Now | Legend Biotech | $59.99 | 50.03% | $65 → $90 | Maintains | Overweight | Get Alert |
| 05/18/2023 | PTCT | Buy Now | PTC Therapeutics | $34.06 | 67.35% | $47 → $57 | Maintains | Equal-Weight | Get Alert |
| 05/11/2023 | BEAM | Buy Now | Beam Therapeutics | $33.09 | 23.9% | $45 → $41 | Maintains | Equal-Weight | Get Alert |
| 05/04/2023 | IONS | Buy Now | Ionis Pharmaceuticals | $51.97 | -28.8% | $40 → $37 | Maintains | Equal-Weight | Get Alert |
| 05/02/2023 | VRTX | Buy Now | Vertex Pharmaceuticals | $495.26 | -22.47% | $342 → $384 | Maintains | Overweight | Get Alert |
| 03/14/2023 | SGEN | Buy Now | Seagen | — | — | $145 → $228 | Maintains | Equal-Weight | Get Alert |
| 02/23/2023 | IONS | Buy Now | Ionis Pharmaceuticals | $51.97 | -23.03% | $44 → $40 | Maintains | Equal-Weight | Get Alert |
| 02/08/2023 | VRTX | Buy Now | Vertex Pharmaceuticals | $495.26 | -30.95% | $313 → $342 | Maintains | Overweight | Get Alert |
| 01/25/2023 | LEGN | Buy Now | Legend Biotech | $59.99 | 8.35% | $53 → $65 | Maintains | Overweight | Get Alert |
| 12/22/2022 | ZYME | Buy Now | Zymeworks BC | $10.62 | -15.25% | $7 → $9 | Maintains | Equal-Weight | Get Alert |
| 12/14/2022 | MRTX | Buy Now | Mirati Therapeutics | — | — | $169 → $90 | Maintains | Overweight | Get Alert |
| 11/11/2022 | SLDB | Buy Now | Solid Biosciences | $8.80 | -9.09% | $2 → $8 | Maintains | Overweight | Get Alert |
| 11/02/2022 | ARCT | Buy Now | Arcturus Therapeutics | $22.39 | 11.66% | $16 → $25 | Upgrade | Underweight → Equal-Weight | Get Alert |
| 10/28/2022 | PTCT | Buy Now | PTC Therapeutics | $34.06 | 37.99% | $48 → $47 | Maintains | Equal-Weight | Get Alert |
| 10/28/2022 | SGEN | Buy Now | Seagen | — | — | $174 → $136 | Maintains | Equal-Weight | Get Alert |
| 10/28/2022 | VRTX | Buy Now | Vertex Pharmaceuticals | $495.26 | -36.8% | $307 → $313 | Maintains | Overweight | Get Alert |
| 10/28/2022 | ALNY | Buy Now | Alnylam Pharmaceuticals | $240.90 | -2.03% | $240 → $236 | Maintains | Overweight | Get Alert |
| 08/10/2022 | BEAM | Buy Now | Beam Therapeutics | $33.09 | 81.32% | $38 → $60 | Maintains | Equal-Weight | Get Alert |
| 08/10/2022 | ARCT | Buy Now | Arcturus Therapeutics | $22.39 | -28.54% | $17 → $16 | Maintains | Underweight | Get Alert |
| 08/09/2022 | CRSP | Buy Now | CRISPR Therapeutics | $57.49 | 53.07% | $99 → $88 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 08/05/2022 | PTCT | Buy Now | PTC Therapeutics | $34.06 | 40.93% | → $48 | Maintains | Equal-Weight | Get Alert |
| 08/05/2022 | BLUE | Buy Now | bluebird bio | $1.22 | 309.84% | $3 → $5 | Upgrade | Underweight → Equal-Weight | Get Alert |
| 08/05/2022 | VRTX | Buy Now | Vertex Pharmaceuticals | $495.26 | -38.01% | $291 → $307 | Maintains | Overweight | Get Alert |
| 08/05/2022 | BCRX | Buy Now | BioCryst Pharma | $7.66 | 82.89% | $12 → $14 | Maintains | Equal-Weight | Get Alert |
| 08/04/2022 | BMRN | Buy Now | Biomarin Pharmaceutical | $85.76 | 45.76% | $112 → $125 | Maintains | Overweight | Get Alert |
| 08/04/2022 | EDIT | Buy Now | Editas Medicine | $5.32 | 219.55% | $16 → $17 | Maintains | Equal-Weight | Get Alert |
| 05/13/2022 | CLLS | Buy Now | Cellectis | $2.04 | 243.14% | $9 → $7 | Maintains | Overweight | Get Alert |
| 05/13/2022 | ORTX | Buy Now | Orchard Therapeutics | — | — | $60 → $40 | Maintains | Overweight | Get Alert |
| 05/13/2022 | MGTX | Buy Now | MeiraGTx Hldgs | $5.07 | 255.03% | $32 → $18 | Maintains | Overweight | Get Alert |
| 05/11/2022 | AVRO | Buy Now | Avrobio | — | — | $72 → $48 | Maintains | Overweight | Get Alert |
| 05/10/2022 | CRSP | Buy Now | CRISPR Therapeutics | $57.49 | 72.2% | $107 → $99 | Maintains | Overweight | Get Alert |
| 05/10/2022 | BLUE | Buy Now | bluebird bio | $1.22 | 145.9% | $4 → $3 | Maintains | Underweight | Get Alert |
| 05/10/2022 | ARCT | Buy Now | Arcturus Therapeutics | $22.39 | -24.07% | $21 → $17 | Maintains | Underweight | Get Alert |
| 05/05/2022 | VRTX | Buy Now | Vertex Pharmaceuticals | $495.26 | -41.24% | → $291 | Maintains | Overweight | Get Alert |
| 05/04/2022 | PTCT | Buy Now | PTC Therapeutics | $34.06 | -0.18% | $39 → $34 | Maintains | Equal-Weight | Get Alert |
| 04/18/2022 | BCRX | Buy Now | BioCryst Pharma | $7.66 | 69.82% | $22 → $13 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 03/21/2022 | DBTX | Buy Now | Decibel Therapeutics | — | — | $30 → $7 | Maintains | Overweight | Get Alert |
| 03/15/2022 | LEGN | Buy Now | Legend Biotech | $59.99 | -11.65% | → $53 | Initiates | → Overweight | Get Alert |
| 03/07/2022 | BLUE | Buy Now | bluebird bio | $1.22 | 227.87% | $13 → $4 | Downgrade | Equal-Weight → Underweight | Get Alert |
| 02/23/2022 | PTCT | Buy Now | PTC Therapeutics | $34.06 | 14.5% | $40 → $39 | Maintains | Equal-Weight | Get Alert |
| 02/07/2022 | KOD | Buy Now | Kodiak Sciences | $3.23 | 1447.99% | $81 → $50 | Maintains | Underweight | Get Alert |
| 01/05/2022 | AVRO | Buy Now | Avrobio | — | — | $264 → $72 | Maintains | Overweight | Get Alert |
| 12/01/2021 | SGTX | Buy Now | Sigilon Therapeutics | — | — | — | Maintains | Overweight | Get Alert |
| 11/17/2021 | LOGC | Buy Now | LogicBio Therapeutics | $5.79 | 38.05% | — | Maintains | Overweight | Get Alert |
| 10/29/2021 | PTCT | Buy Now | PTC Therapeutics | $34.06 | 17.44% | $45 → $40 | Maintains | Equal-Weight | Get Alert |
| 04/21/2021 | VRTX | Buy Now | Vertex Pharmaceuticals | $495.26 | -39.02% | → $302 | Maintains | Overweight | Get Alert |
| 03/09/2021 | AVRO | Buy Now | Avrobio | — | — | → $276 | Initiates | → Overweight | Get Alert |
| 10/30/2020 | VRTX | Buy Now | Vertex Pharmaceuticals | $495.26 | -38.01% | $315 → $307 | Maintains | Overweight | Get Alert |
| 10/29/2020 | MRTX | Buy Now | Mirati Therapeutics | — | — | $143 → $244 | Maintains | Overweight | Get Alert |
| 08/07/2020 | MRTX | Buy Now | Mirati Therapeutics | — | — | $123 → $143 | Maintains | Overweight | Get Alert |
| 07/31/2020 | VRTX | Buy Now | Vertex Pharmaceuticals | $495.26 | -36.4% | $280 → $315 | Maintains | Overweight | Get Alert |
| 03/20/2020 | VRTX | Buy Now | Vertex Pharmaceuticals | $495.26 | — | — | Initiates | → Overweight | Get Alert |
| 06/05/2019 | MRTX | Buy Now | Mirati Therapeutics | — | — | $85 → $123 | Maintains | Overweight | Get Alert |
